Association of sleep duration with rheumatoid arthritis in Korean adults: analysis of seven years of aggregated data from the Korea National Health and Nutrition Examination Survey (KNHANES). by 諛뺤�泥� & �씠�긽洹�
Association of sleep duration with
rheumatoid arthritis in Korean adults:
analysis of seven years of aggregated
data from the Korea National Health
and Nutrition Examination Survey
(KNHANES)
Jae-Hyun Kim,1,2 Eun-Cheol Park,3,4 Kwang Soo Lee,5 Yunhwan Lee,1,2
Sungkeun Shim,6 Jinhee Kim,1,2 Doukyoung Chon,1,2 Sang-Gue Lee4,7
To cite: Kim J-H, Park E-C,
Lee KS, et al. Association of
sleep duration with
rheumatoid arthritis in
Korean adults: analysis of
seven years of aggregated
data from the Korea National
Health and Nutrition
Examination Survey
(KNHANES). BMJ Open
2016;6:e011420.
doi:10.1136/bmjopen-2016-
011420
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2016-011420).
Received 5 February 2016
Revised 13 October 2016
Accepted 18 October 2016
For numbered affiliations see
end of article.
Correspondence to
Dr Sang-Gue Lee;
LEEVAN@yuhs.ac
ABSTRACT
Objectives: To investigate the association between
rheumatoid arthritis (RA) and self-reported sleep
duration.
Setting: The present study analysed 7 years of
aggregated cross-sectional data (2007–2013) from the
Korea National Health and Nutrition Examination
Surveys (KNHANES).
Participants: A total of 37 979 individuals were
selected for the analyses.
Interventions: RA.
Primary and secondary outcome measures:
Sleep duration.
Results: After adjusting for confounding factors, the
odds of short-duration sleepers (≤6 hours/day) and
long-duration sleepers (≥9 hours/day) for RA were
1.23-fold (95% CI 1.101 to 1.51) and 1.27-fold (95%
CI 0.85 to 1.88) higher, respectively, than those for
persons with sleep duration of 7–8 hours/day. A
subgroup analysis according to the extent of pain in
RA revealed that the strong relationship between RA
and sleep disturbances was observed in those with
high pain from RA (OR: 1.28 CI 1.04 to 1.58).
Conclusions: Individuals with RA may be at a higher
risk for sleep disturbances compared with individuals
without RA. Therefore, the provision of comprehensive
care for patients with RA by healthcare professionals
should include assessments of sleep duration and
patients with RA should be encouraged to report sleep
problems.
INTRODUCTION
Arthritis is the most common cause of dis-
ability worldwide. Rheumatoid arthritis (RA)
is characterised by persistent inﬂammatory
symmetrical synovitis with pain, swelling and
a broad range of systemic manifestations in
the peripheral joints.1 This disease is also
associated with sleep disturbances2 which
play an important role in the maintenance of
an individual’s health.3 4 Importantly, poor
sleep in patients with RA could originate from
pain or may contribute to increased level of
pain and fatigue.5 6 Additionally, sleep disor-
ders such as sleep apnoea or primary insom-
nia typically result in poor sleep quality in
patients with RA as well as exacerbating the
patient’s primary symptoms.7
Sleep disturbances affect more than half of
patients with RA8 9 and are thought to be
more common among those with active
inﬂammation10 or physical health conditions
such as associated pain, fatigue and/or func-
tional disabilities.11 Although physicians
often assume that inﬂammation is the stimu-
lus for RA-related pain, many of these
Strengths and limitations of this study
▪ This study used nationwide survey data of com-
munity dwelling people. A large population
sample size was representative of the general
population, so that the results can be generalised
to the general population in South Korea.
▪ The lack of validated questionnaires assessing
rheumatoid arthritis and sleep duration was a
major limitation of the present study, as more
objective methods tend to yield more accurate
results.
▪ Respondents’ reports were subjective and were
imperfect measures potentially affected by per-
ception bias and adaptation of resources.
▪ We used cross-sectional nature data for our esti-
mates. Therefore, the results possibly reflected
reverse causality and are bidirectional.
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patients continue to experience pain following adequate
suppression of inﬂammation.12 Furthermore, sleep dis-
turbances and inadequate sleep are related to serious
outcomes such as reduced health-related quality of
life,13 a higher risk of morbidities14 and, ultimately,
increase in all-cause mortality.15 Additionally, sleep dis-
turbances are almost threefold more frequent in females
than males.16 Thus, the quality and amount of sleep in
patients with RA are important issues for rheumatolo-
gists, particularly after the ﬁnding that etanercept and
inﬂiximab’s ability to reduce daytime sleepiness.17
Therefore, the primary aim of the present study was to
investigate the association between RA and self-reported
sleep duration using 7 years of aggregated cross-sectional
data (2007–2013) obtained from the Korea National
Health and Nutrition Examination Survey (KNHANES).
METHODS
Study sample
To evaluate the relationship between sleep duration and
RA, the present study analysed data from the fourth
(2007–2009), ﬁfth (2010–2012) and sixth (2013)
KNHANES assessments performed by the Korean
Ministry of Health and Welfare. The KNHANES is a
cross-sectional survey based on stratiﬁed multistage prob-
ability sampling units of Korean households that targets
members of the civilian non-institutionalised South
Korean population who are 1-year of age or older. The
samples were determined by the household registries of
the 2005 National Census Registry.
The total target population initially consisted of
24 871, 25 534 and 8018 participants who completed the
2007–2009, 2010–2012 and 2013 KNHANES assessments,
which had average response rates of 78.4%, 80.8% and
79.3%, respectively. The information from 14 305 in-
dividuals aged 1–18 years old were excluded from
the present analyses while the information of 44 118
individuals aged 19 years and older were included.
Additionally, the present study excluded 6036 individuals
with missing data regarding age, occupation, income
and/or marriage status and 103 individuals with missing
data regarding smoking, drinking, perceived stress, exer-
cise, sleep duration, RA, hypertension, and/or dyslipi-
daemia. Thus, a total of 37 979 individuals were selected
for the ﬁnal analyses in the present study. Since all
KNHANES data are available publicly, this study did not
require approval from an institutional review board.
Variables
Dependent variables
In the present study, sleep duration was based on self-
reported data acquired in response to the question
‘How many hours do you usually sleep?’. The responses
were classiﬁed into three categories (≤6 hours,
7–8 hours and≥9 hours) based on the sleep deﬁnitions
of the International Classiﬁcation of Sleep Disorders,
2nd edition, in which ≤6 hours is deﬁned as a short
sleeper and ≥9 hours as a long sleeper.18
Independent variables
In the present study, diabetes mellitus type 2 cases were
considered to be the participants who answered ‘Yes’ to
the question ‘Are you currently suffering from RA?’ in
the self-reported data. RA was categorised as either ‘Yes’
or ‘No’.
Sociodemographic factors
The present analyses included age, gender, household
income, marital status, occupation and region of resi-
dency as sociodemographic factors; all of the covariates
were categorical. Individual income was calculated by
dividing a participant’s household monthly income by
the square root of the household size, and the partici-
pants were ranked from lowest to highest income and
then grouped into four household income quartiles.
Predeﬁned categories were used to categorise household
incomes, similar to how the raw KNHANES data are pro-
cessed. The residency regions were categorised into
urban (administrative divisions of a city: Seoul, Daejeon,
Daegu, Busan, Incheon, Kwangju or Ulsan) and rural
(not classiﬁed as administrative of a city), and occupa-
tional status was classiﬁed into the following three cat-
egories: white collar (administrative, engineering,
scientiﬁc, teaching and related occupations, sales and
related occupations, and service occupation), blue collar
(farming, forestry, ﬁshing and hunting, craft and repair,
operators, fabricators, and labourers) and unpaid
employment (including housewives and students).
Health behaviour factors
Questions regarding alcohol use, smoking status and the
number of days of moderate exercise per week were
assessed by a health interview survey and included as
covariates in the present analyses. Alcohol use was
further assessed by questioning the participants about
their average frequency (days per week or month) of
alcohol use during the past year.
Health status factors
Perceived stress, the extent of RA pain and body mass
index (BMI) were also included in the present model.
The following were categorised into four groups for the
present analyses: perceived stress (very high, high, low
and very low), and BMI (thin: <18.5 kg/m2 moderate:
18.5–23.9 kg/m2, overweight: 24.0–26.9 kg/m2 and
obese: >27.0 kg/m2).19 Extent of RA pain was measured
by asking the respondents to assess the extent suffering
from RA using a pictorial representation of 0–10 scores.
Extent of RA pain was categorised into two groups: Low
(0–5) or High (6–10).
Statistical analysis
The distributions of the general characteristics of the
participants were assessed using χ2 tests, and
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Table 1 Demographic characteristics of the study population
Sleep duration
Total
Short sleeper
(≤6 hours)
Appropriate
sleeper
(7–8 hours)
Long sleeper
(≥9 hours)
p ValueN Per cent N Per cent N Per cent N Per cent
Rheumatoid arthritis (RA) <0.0001
No 37 309 98.2 15 508 40.8 18 883 49.7 2918 7.7
Yes 670 1.8 347 51.8 58 8.7 265 39.6
Age (year) <0.0001
≤29 4751 12.5 1566 33.0 2569 54.1 616 13.0
30–49 14 551 38.3 5476 37.6 8259 56.8 816 5.6
50–69 13 135 34.6 6001 45.7 6253 47.6 881 6.7
≥79 5542 14.6 2812 50.7 2067 37.3 663 12.0
Gender <0.0001
Male 16 254 42.8 6732 41.4 8357 51.4 1165 7.2
Female 21 725 57.2 9123 42.0 10 791 49.7 1811 8.3
Household income level <0.0001
Low 7633 20.1 3592 47.1 3226 42.3 815 10.7
Lower middle 9685 25.5 4102 42.4 4790 49.5 793 8.2
Upper middle 10 216 26.9 3980 39.0 5462 53.5 774 7.6
High 10 445 27.5 4181 40.0 5670 54.3 594 5.7
Marital status <0.0001
Married 27 602 72.7 11 246 40.7 14 338 52.0 2018 7.3
Single 5312 14.0 1889 35.6 2876 54.1 547 10.3
Separated, divorced 5065 13.3 2720 53.7 1934 38.2 411 8.1
Occupation <0.0001
White collar 12 635 33.3 5171 40.9 6846 54.2 618 4.9
Blue collar 10 340 27.2 4488 43.4 5073 49.1 779 7.5
Unpaid employment 15 004 39.5 6196 41.3 7229 48.2 1579 10.5
Residential region <0.0001
Urban 17 032 44.9 7363 43.2 8517 50.0 1152 6.8
Rural 20 947 55.2 8492 40.5 10 631 50.8 1824 8.7
Smoking status 0.402
Current smoker 11 101 29.2 4564 41.1 5633 50.7 904 8.1
Former smoker 4552 12.0 1927 42.3 2280 50.1 345 7.6
Never smoked 22 326 58.8 9364 41.9 11 235 50.3 1727 7.7
Frequency of alcohol use <0.0001
Never drink 10 950 28.8 4947 45.2 5018 45.8 985 9.0
1 times or less per month 10 786 28.4 4238 39.3 5734 53.2 814 7.6
2–4 times per week 13 510 35.6 5462 40.4 7122 52.7 926 6.9
4 times or more per week 2733 7.2 1208 44.2 1274 46.6 251 9.2
Number of days of moderate exercise per
week
<0.0001
Never 23 187 61.1 9718 41.9 11 457 49.4 2012 8.7
1–3 9145 24.1 3741 40.9 4829 52.8 575 6.3
4–6 3318 8.7 1361 41.0 1761 53.1 196 5.9
Everyday 2329 6.1 1035 44.4 1101 47.3 193 8.3
Perceived stress <0.0001
Very high 1749 4.6 920 52.6 685 39.2 144 8.2
High 8442 22.2 3960 46.9 3887 46.0 595 7.1
Low 21 556 56.8 8495 39.4 11 480 53.3 1581 7.3
Very low 6232 16.4 2480 39.8 3096 49.7 656 10.5
Extent of pain from RA <0.0001
Low 36 660 96.5 15 099 41.2 18 708 51.0 2853 7.8
High 1319 3.5 756 57.3 440 33.4 123 9.3
Continued
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multinomial logistic regression analyses were used to
determine whether the general characteristics, health
statuses and/or health risk behaviours of the partici-
pants had relationships with RA. All data were analysed
using SAS software, V.9.4 (SAS Institute; Cary, North
Carolina, USA).
RESULTS
Prevalence of short sleep and long sleep durations
Of the 37 979 KNHANES participants included in the
present study, 16 254 were men (42.8%), 21 735 were
women (57.2%) and 670 were patients with RA (1.8%).
Of the 15 855 participants who reported a short sleeper
(≤6 hours), 347 had RA (51.8%), while of the 2976 par-
ticipants who reported a long sleeper (≥9 hours), 265
had RA (39.6%; table 1).
Association between sleep duration and RA
Table 2 portrays the results of the logistic regression ana-
lyses after adjusting for age, gender, household income,
marital status, occupation, region of residence, smoking
status, frequency of alcohol use, number of days of mod-
erate exercise per week, perceived stress, extent of RA
pain, BMI and year of the survey. After adjusting for all
of these confounding variables, in terms of RA, the odds
of short sleep (≤6 hours/day) were 1.23-fold higher
(95% CI 1.01 to 1.51) and the odds of long sleep
(≥9 hours/day) were 1.27-fold higher (95% CI 0.85 to
1.88) than for those with sleep durations of 7–8 hours/
day (table 2).
Table 3 depicts the results of a subgroup analysis
according to the extent of RA pain after adjusting for
age, household income, marital status, occupation, region
of residence, smoking status, frequency of alcohol use,
number of days of moderate exercise per week, perceived
stress, BMI and year of the survey. Those who reported
RA were 28% more likely to have short sleep (OR: 1.28,
95% CI 1.04 to 1.58), while those who did not report RA
were not more likely to have short sleep (OR: 0.84, 95%
CI 0.49 to 1.46), compared with those with reported sleep
durations of 7–8 hours (table 3).
DISCUSSION
Since sleep disturbances may be an important clinical
feature for patients with RA, this issue has recently
received an increasing amount of attention.20 21 Thus,
the present study aimed to investigate RA and its rela-
tionship with sleep duration using 7 years of aggregated
data from a large representative population-based survey
conducted in Korea. The present study found an associ-
ation between RA and the reported symptoms of short
sleep duration that was statistically signiﬁcant (OR: 1.23,
95% CI 1.01 to 1.51) even in the presence of perceived
stress, which suggests that stress could be a trigger or
signal for an inappropriate sleep duration in patients
with RA. In general, there is a U-shaped association
between RA and short or long sleep duration, and this
similarly shaped relationship was evident in this study. In
addition, in a subgroup analysis based on the extent of
pain in RA, these associations were statistically signiﬁcant
only in those with high pain from RA. These associations
were independent of sociodemographic variables, (eg,
age, gender, household income level, marital status,
occupation and region of residence), health behaviour
variables (eg, smoking status, frequency of alcohol use
and number of days of moderate exercise per week),
and health status variables (eg, perceived stress, the
extent of RA pain, BMI), and year of the survey.
Table 1 Continued
Sleep duration
Total
Short sleeper
(≤6 hours)
Appropriate
sleeper
(7–8 hours)
Long sleeper
(≥9 hours)
p ValueN Per cent N Per cent N Per cent N Per cent
BMI <0.0001
Thin (<18.5 kg/m2) 1908 5.0 656 34.4 1010 52.9 242 12.7
Moderate (18.5kg/m-23.9kg/m2) 19 689 51.8 7970 40.5 10 153 51.6 1566 8.0
Overweight (24.0kg/m-26.9kg/m2) 10 767 28.4 4649 43.2 5351 49.7 767 7.1
Obese (≥27.0 kg/m2) 5615 14.8 2580 46.0 2634 46.9 401 7.1
Year <0.0001
2007 1403 3.7 576 41.1 747 53.2 80 5.7
2008 6513 17.2 2672 41.0 3258 50.0 583 9.0
2009 7338 19.3 2922 39.8 3796 51.7 620 8.5
2010 6059 16.0 2461 40.6 3114 51.4 484 8.0
2011 5927 15.6 2535 42.8 2947 49.7 445 7.5
2012 5465 14.4 2303 42.1 2762 50.5 400 7.3
2013 5274 13.9 2386 45.2 2524 47.9 364 6.9
Total 37 979 100.0 15 855 41.8 19 148 50.4 2976 7.8
BMI, body mass index.
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Table 2 Results of logistic regression between rheumatoid arthritis and sleep duration
RA
Appropriate sleeper
(7–8 hours)
Short sleeper
(≤6 hours)
Long sleeper
(≥9 hours)
Ref OR 95% CI OR 95% CI
RA
No 1.00
Yes 1.23 (1.01 to 1.51) 1.27 (0.85 to 1.88)
Age (year)
≤29 1.00
30–49 1.16 (1.04 to 1.31) 0.45 (0.37 to 0.55)
50–69 1.49 (1.32 to 1.69) 0.51 (0.42 to 0.63)
≥79 2.15 (1.85 to 2.50) 0.84 (0.65 to 1.08)
Gender
Male 1.02 (0.95 to 1.10) 0.64 (0.55 to 0.74)
Female 1.00
Household income level
Low 1.04 (0.95 to 1.14) 1.50 (1.27 to 1.77)
Lower middle 1.01 (0.93 to 1.09) 1.25 (1.09 to 1.44)
Upper middle 0.95 (0.89 to 1.02) 1.25 (1.08 to 1.44)
High 1.00
Marital status
Married 1.00
Single 1.11 (1.00 to 1.23) 0.99 (0.82 to 1.21)
Separated, divorced 1.49 (1.37 to 1.62) 0.90 (0.77 to 1.06)
Occupation
White collar 1.00
Blue collar 1.05 (0.97 to 1.12) 1.32 (1.14 to 1.54)
Unpaid employment 0.87 (0.81 to 0.93) 1.78 (1.55 2.04)
Residential region
Urban 1.00
Rural 0.88 (0.83 to 0.94) 1.24 (1.12 to 1.38)
Smoking status
Current smoker 0.99 (0.92 to 1.08) 1.51 (1.31 to 1.75)
Former smoker 0.95 (0.85 to 1.05) 1.51 (1.26 to 1.81)
Never smoked 1.00
Frequency of alcohol use
Never drink 0.96 (0.85 to 1.09) 0.88 (0.71 to 1.09)
1 times or less per month 0.89 (0.79 to 1.01) 0.81 (0.65 to 1.00)
2–4 times per week 0.93 (0.83 to 1.04) 0.79 (0.65 to 0.96)
4 times or more per week 1.00
Number of days of moderate exercise per week
Never 1.00
1–3 0.98 (0.92 to 1.05) 0.75 (0.66 to 0.86)
4–6 0.99 (0.90 to 1.09) 0.70 (0.57 to 0.85)
Everyday 1.09 (0.98 to 1.22) 1.04 (0.84 to 1.28)
Perceived stress
Very high 1.88 (1.64 to 2.16) 1.19 (0.93 to 1.51)
High 1.57 (1.44 to 1.71) 0.86 (0.74 to 1.01)
Low 1.12 (1.04 to 1.21) 0.85 (0.75 to 0.97)
Very low 1.00
Extent of pain from RA
Low 1.00
High 1.39 (1.19 to 1.63) 1.22 (0.93 to 1.58)
BMI
Thin (<18.5 kg/m2) 0.79 (0.70 to 0.90) 1.26 (1.04 to 1.53)
Moderate (18.5kg/m-23.9kg/m2) 1.00
Overweight (24.0kg/m-26.9kg/m2) 1.05 (0.99 to 1.11) 0.95 (0.84 to 1.07)
Obese (≥27.0 kg/m2) 1.20 (1.11 to 1.29) 1.00 (0.86 to 1.17)
Continued
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A nationwide study conducted in the USA found that
RA is associated with sleep disturbances in ∼10 million
adults.22 The presence of sleep disturbances in patients
diagnosed with a range of rheumatological-related dis-
eases including systemic lupus erythematosus, ﬁbromyal-
gia, chronic fatigue syndrome, multiple sclerosis and RA
have also been assessed.23 Additionally, recent studies
have indicated that sleep disturbances from other causes
such as difﬁculties with the onset of sleep and waking
up early in the morning are also major symptoms in
patients with RA, and that fatigue in patients with RA is
likely due to poor quality of sleep, a functional disability,
joint pain and/or depressive symptoms.23–27 Poor quality
of sleep and sleep disturbances can worsen physical and
mental health conditions, including RA symptoms and
pain, in the general population.28 Similarly, the pain
and discomfort caused by RA with inﬂammation may
result in a greater frequency of sleep disturbances, con-
tributing to functional impairments such as poor sleep
quality which have a signiﬁcantly negative impact on the
health and well-being of individuals.29
Along with a signiﬁcantly higher prevalence of fatigue,
there is also a greater risk of sleep disturbances from
causes such as obstructive sleep apnoea (OSA) in
patients with RA, because they are more likely to have
chronic health issues, including high blood pressure
and high BMI. This consequently leads to increased
risks of cardiovascular disease and nocturnal sudden
cardiac death.30 Accordingly, the autonomic response is
more severe in patients with chronic OSA than in indivi-
duals with a low risk of OSA.30–33
In the present study, a multinomial logistic regression
analysis revealed that the important factors inﬂuencing
the relationship between RA and sleep duration include
perceived stress and the extent of RA pain. Although
the causes of sleep disturbances in patients with RA are
likely multifactorial, only 30% of older Americans with
sleep disturbances seek treatment at hospitals or treat-
ment centres using multidisciplinary approaches, relying
on various self-care strategies instead.34 35 Therefore, the
provision of comprehensive care for patients with RA
requires encouraging the patient to report sleep distur-
bances as well as conducting timely diagnoses to reduce
their symptoms. In this manner, the present data regard-
ing the prevalence of sleep disturbances in patients with
RA will contribute to the awareness of physicians and
healthcare professionals regarding this issue and may
aid in the development of appropriate interventions
Table 2 Continued
RA
Appropriate sleeper
(7–8 hours)
Short sleeper
(≤6 hours)
Long sleeper
(≥9 hours)
Ref OR 95% CI OR 95% CI
Year
2007 1.00
2008 1.05 (0.89 to 1.24) 1.30 (0.98 to 1.73)
2009 0.95 (0.80 to 1.12) 1.19 (0.90 to 1.57)
2010 1.00 (0.84 to 1.19) 1.22 (0.91 to 1.64)
2011 1.03 (0.86 to 1.23) 1.10 (0.82 to 1.47)
2012 1.00 (0.84 to 1.19) 1.14 (0.85 to 1.54)
2013 1.16 (0.98 to 1.38) 1.04 (0.78 to 1.40)
BMI, body mass index;RA, rheumatoid arthritis.
Table 3 Results of logistic regression between rheumatoid arthritis and sleep duration by extent to pain of rheumatoid
arthritis
RA
Appropriate sleeper
(7–8 hour)
Short sleeper
(≤6 hour)
Long sleeper
(≥9 hour)
Ref OR 95% CI OR 95% CI
Extent to pain of rheumatoid arthritis (high)
RA
No 1.00
Yes 1.28 (1.04 to 1.58) 1.40 (0.93 to 2.12)
Extent to pain of rheumatoid arthritis (low)
RA
No 1.00
Yes 0.84 (0.49 to 1.46) 0.52 (0.18 to 1.45)
*Adjusted for all variables
RA, rheumatoid arthritis.
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to properly manage, minimise or eliminate these
symptoms.
There are several potential limitations that should be
taken into consideration when interpreting the present
results. First, because this study used a cross-sectional
design, the results may reﬂect reverse causality and a
bidirectional relationship in the association between RA
and sleep duration. Therefore, longitudinal studies
using validated measures of RA and sleep duration are
required to see if these ﬁndings can be replicated and
to clarify the causality and mechanisms that underlie the
association between RA and sleep duration. Second,
although the use of self-reports is a valuable source of
information in large-scale epidemiological studies, the
lack of validated questionnaires assessing RA and sleep
duration was a major limitation of the present study, as
more objective methods tend to yield more accurate
results. Controlling for socioeconomic status, health
status and behaviour variables, as in the present study,
may partially ameliorate these issues, but future in-depth
studies are necessary to determine more accurately the
relationship between RA and sleep disturbances, includ-
ing difﬁculty falling asleep, difﬁculty maintaining sleep,
time spent in bed, waking after sleep onset, sleep onset
latency, sleep quality, time of going to bed in the
evening, time of turning out the lights with the inten-
tion to sleep, wake time in the morning, time of getting
out of bed in the morning and insomnia.
CONCLUSIONS
The present study found that patients with RA may be at
a higher risk for sleep disturbances than are individuals
without RA. This apparent difference may be attributed
to pain reported by patients with RA, which may also be
associated with RA itself. The present ﬁndings suggest
that healthcare professionals who treat patients with RA
in routine clinical practice should be aware of the rela-
tionship between RA and sleep disturbances. Future
research that includes objective measures of sleep distur-
bances is necessary to fully characterise the extent to
which sleep disturbances affect patients with RA.
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